Methotrexate - Safe Backbone for the Treatment of Rheumatoid Arthritis

被引:0
作者
Krasselt, Marco [1 ]
机构
[1] Univ Leipzig, Med Clic 3, Med Ctr, Dept Endocrinol Nephrol & Rheumatol, Liebigstr 20, D-04103 Leipzig, Germany
关键词
Methotrexate; MTX; rheumatoid arthritis; safety; folic acid; intoxication; LOW-DOSE METHOTREXATE; INTERSTITIAL LUNG-DISEASE; FOLIC-ACID; TRIMETHOPRIM-SULFAMETHOXAZOLE; SUBCUTANEOUS METHOTREXATE; CAFFEINE CONSUMPTION; ORAL METHOTREXATE; DRUG-INTERACTIONS; CONCOMITANT USE; ADVERSE EVENTS;
D O I
10.2174/0115733971317122240626053727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methotrexate (MTX) is the primarily used disease-modifying antirheumatic drug (DMARD) for the treatment of Rheumatoid Arthritis (RA). MTX is a safe agent, even when used for years - provided that treatment is regularly monitored and prescribers follow some simple rules, such as prescribing tablets of a single strength only. Proper patient education contributes greatly to safe treatment. The knowledge of important pharmacologic facts, possible interactions, and clinical warning signs also helps to prevent or recognize intoxications early.Therefore, this review addresses key aspects regarding the safety of MTX. In this respect, it includes adverse events, possible interactions with frequently used drugs and details on the rare but life-threatening intoxication, e.g., due to erroneous daily intake.
引用
收藏
页码:169 / 181
页数:13
相关论文
共 122 条
  • [111] Adverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers
    Vial, Thierry
    Patat, Anne Marie
    Boels, David
    Castellan, Delphine
    Villa, Antoine
    Theophile, Helene
    Torrents, Romain
    Kassai, Behrouz
    [J]. JOINT BONE SPINE, 2019, 86 (03) : 351 - 355
  • [112] Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
    Visser, K.
    Katchamart, W.
    Loza, E.
    Martinez-Lopez, J. A.
    Salliot, C.
    Trudeau, J.
    Bombardier, C.
    Carmona, L.
    van der Heijde, D.
    Bijlsma, J. W. J.
    Boumpas, D. T.
    Canhao, H.
    Edwards, C. J.
    Hamuryudan, V.
    Kvien, T. K.
    Leeb, B. F.
    Martin-Mola, E. M.
    Mielants, H.
    Mueller-Ladner, U.
    Murphy, G.
    Ostergaard, M.
    Pereira, I. A.
    Ramos-Remus, C.
    Valentini, G.
    Zochling, J.
    Dougados, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) : 1086 - 1093
  • [113] Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis
    Wang, Xi
    Song, Yanqin
    Wang, Jingjing
    He, Jin
    Liu, Ruming
    Li, Xiaosu
    Huang, Hua
    Zhang, Jun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 23 - 30
  • [114] Wasila M., 2019, mediX
  • [115] Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate
    Watts, Courtney S.
    Sciasci, Joseph N.
    Pauley, Jennifer L.
    Panetta, John C.
    Pei, Deqing
    Cheng, Cheng
    Christensen, Caroline M.
    Mikkelsen, Torben S.
    Pui, Ching-Hon
    Jeha, Sima
    Relling, Mary V.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (06) : 449 - 452
  • [116] Methotrexate: who would have predicted its importance in rheumatoid arthritis?
    Weinblatt, Michael E.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [117] Use of Methotrexate in Girls and Women of Childbearing Age, Occurrence of Methotrexate-Exposed Pregnancies and Their Outcomes in Germany: A Claims Data Analysis
    Wentzell, Nadine
    Kollhorst, Bianca
    Reinold, Jonas
    Haug, Ulrike
    [J]. CLINICAL DRUG INVESTIGATION, 2023, 43 (02) : 109 - 117
  • [118] WHO World Health Organization, 2021, Model List of Essential Medicines: 22nd List
  • [119] Association Between Low-Dose Methotrexate Exposure and Melanoma A Systematic Review and Meta-analysis
    Yan, Mabel K.
    Wang, Charlie
    Wolfe, Rory
    Mar, Victoria J.
    Wluka, Anita E.
    [J]. JAMA DERMATOLOGY, 2022, 158 (10) : 1157 - 1166
  • [120] Yazici Y, 2005, CLIN EXP RHEUMATOL, V23, P517